Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totaling 66,933 shares, a drop of 52.9% from the June 30th total of 142,100 shares. Based on an average daily trading volume, of 8,132,292 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

Advanced Medical Isotope Stock Performance

Shares of RDGL opened at $0.06 on Tuesday. The stock has a market capitalization of $29.19 million, a P/E ratio of -5.91 and a beta of -0.75. Advanced Medical Isotope has a 1 year low of $0.04 and a 1 year high of $0.14. The company’s fifty day moving average is $0.06 and its two-hundred day moving average is $0.07.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.